Remdesivir para tratamento de pacientes com COVID-19

Secretaria de Ciência, Tecnologia e Insumos Estratégicos em Saúde (Brasil)

Remdesivir para tratamento de pacientes com COVID-19 / Remdesivir for the treatment of patients with COVID-19

Secretaria de Ciência, Tecnologia e Insumos Estratégicos em Saúde (Brasil).

s.l; s.n; jun. 2020. 19 p.

Non-conventional in Portuguese | LILACS, ColecionaSUS | ID: biblio-1116674

Subject(s)

Humans; Antiviral Agents/therapeutic use; Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; COVID-19/drug therapy; Severity of Illness Index; Cost-Benefit Analysis; Therapeutic Index

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Antiviral Agents / Adenosine Monophosphate / Alanine / COVID-19 Type of study: Evaluation studies / Systematic reviews Limits: Humans Language: Portuguese Year: 2020 Type: Non-conventional

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google